Targeted delivery of polyamidoamine-paclitaxel conjugate functionalized with anti-human epidermal growth factor receptor 2 trastuzumab

Código QR

Targeted delivery of polyamidoamine-paclitaxel conjugate functionalized with anti-human epidermal growth factor receptor 2 trastuzumab

Pengkai Ma,1 Xuemei Zhang,1 Ling Ni,2 Jinming Li,2 Fengpu Zhang,1 Zheng Wang,1 Shengnan Lian,1 Kaoxiang Sun1 1School of Pharmacy, Yantai University, Yantai, Shandong Province, People’s Republic of China; 2State Key Laboratory of Long-acting and Targeting Drug Delivery System, Yantai, Sha...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ma P, Zhang X, Ni L, Li J, Zhang F, Wang Z, Lian S, Sun K
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2015
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/3620006dc9a24f99aef685df09951068
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Aptamer-Conjugated Gold Nanoparticles Targeting Epidermal Growth Factor Receptor Variant III for the Treatment of Glioblastoma
por: Peng L, et al.
Publicado: (2020)

Aptamer-conjugated PEGylated quantum dots targeting epidermal growth factor receptor variant III for fluorescence imaging of glioma
por: Tang J, et al.
Publicado: (2017)

Dicer increases the indication for trastuzumab treatment in gastric cancer patients via overexpression of human epidermal growth factor receptor 2
por: Jianhua Wu, et al.
Publicado: (2021)

Polymeric nanoparticles conjugate a novel heptapeptide as an epidermal growth factor receptor-active targeting ligand for doxorubicin
por: Liu CW, et al.
Publicado: (2012)

Targeted delivery of doxorubicin-utilizing chitosan nanoparticles surface-functionalized with anti-Her2 trastuzumab
por: Yousefpour P, et al.
Publicado: (2011)

Diffusion Reflection Method for Early Detection of Oral Squamous Cell Carcinoma Specifically Targeted by Circulating Gold-Nanorods Bio-Conjugated to Anti-Epidermal Growth Factor Receptor
por: Sudri S, et al.
Publicado: (2021)

Targeted Delivery of Epidermal Growth Factor to the Human Placenta to Treat Fetal Growth Restriction
por: Lewis J. Renshall, et al.
Publicado: (2021)

Arginine–glycine–aspartic acid–polyethylene glycol–polyamidoamine dendrimer conjugate improves liver-cell aggregation and function in 3-D spheroid culture
por: Chen Z, et al.
Publicado: (2016)

Treatment of pancreatic cancer with epidermal growth factor receptor-targeted therapy
por: Bryan A Faller, et al.
Publicado: (2009)

The Impact of Tumor Mutation Burden on the Effect of Frontline Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2-Positive Advanced Gastric Cancers
por: Hye Ryeon Kim, et al.
Publicado: (2021)

Targeted paclitaxel‐octreotide conjugates inhibited the growth of paclitaxel‐resistant human non‐small cell lung cancer A549 cells in vitro
por: Yanguo Liu, et al.
Publicado: (2021)

Development of octreotide-conjugated polymeric prodrug of bufalin for targeted delivery to somatostatin receptor 2 overexpressing breast cancer in vitro and in vivo
por: Liu T, et al.
Publicado: (2016)

Inhibition of cell proliferation and migration through nucleobase-modified polyamidoamine-mediated p53 delivery
por: Han H, et al.
Publicado: (2018)

Sodium cholate-enhanced polymeric micelle system for tumor-targeting delivery of paclitaxel
por: Zhang X, et al.
Publicado: (2017)

Superparamagnetic iron oxide nanoparticles conjugated with epidermal growth factor (SPION–EGF) for targeting brain tumors
por: Shevtsov MA, et al.
Publicado: (2014)

Folate-modified lipid–polymer hybrid nanoparticles for targeted paclitaxel delivery
por: Zhang L, et al.
Publicado: (2015)

Comparison of anti-EGFR-Fab’ conjugated immunoliposomes modified with two different conjugation linkers for siRNA delivery in SMMC-7721 cells
por: Deng L, et al.
Publicado: (2013)

A water-soluble nucleolin aptamer-paclitaxel conjugate for tumor-specific targeting in ovarian cancer
por: Fangfei Li, et al.
Publicado: (2017)

A novel small peptide as an epidermal growth factor receptor targeting ligand for nanodelivery in vitro
por: Han CY, et al.
Publicado: (2013)

In vivo anticancer evaluation of the hyperthermic efficacy of anti-human epidermal growth factor receptor-targeted PEG-based nanocarrier containing magnetic nanoparticles
por: Baldi G, et al.
Publicado: (2014)

Inhibition of proliferation and migration of tumor cells through phenylboronic acid-functionalized polyamidoamine-mediated delivery of a therapeutic DNAzyme Dz13
por: Yang J, et al.
Publicado: (2019)

Clinical effects of prior trastuzumab on combination eribulin mesylate plus trastuzumab as first-line treatment for human epidermal growth factor receptor 2 positive locally recurrent or metastatic breast cancer: results from a Phase II, single-arm, multicenter study
por: Puhalla S, et al.
Publicado: (2016)

Low density lipoprotein mimic nanoparticles composed of amphipathic hybrid peptides and lipids for tumor-targeted delivery of paclitaxel
por: Qian J, et al.
Publicado: (2019)

Antitumor Activity of α-Linolenic Acid-Paclitaxel Conjugate Nanoparticles: In vitro and in vivo
por: Xu MQ, et al.
Publicado: (2021)

tLyP-1 Peptide Functionalized Human H Chain Ferritin for Targeted Delivery of Paclitaxel
por: Ma Y, et al.
Publicado: (2021)

Second-generation aptamer-conjugated PSMA-targeted delivery system for prostate cancer therapy
por: Zhu Q, et al.
Publicado: (2011)

Reprogramming fibroblasts to pluripotency using arginine-terminated polyamidoamine nanoparticles based non-viral gene delivery system
por: Zhu K, et al.
Publicado: (2014)

Folate-targeted paclitaxel-conjugated polymeric micelles inhibits pulmonary metastatic hepatoma in experimental murine H22 metastasis models
por: Zhang Y, et al.
Publicado: (2014)

Physicochemical properties and biocompatibility of a polymer-paclitaxel conjugate for cancer treatment
por: Yang D, et al.
Publicado: (2011)

Co-Administration Of iRGD Enhances Tumor-Targeted Delivery And Anti-Tumor Effects Of Paclitaxel-Loaded PLGA Nanoparticles For Colorectal Cancer Treatment
por: Zhong Y, et al.
Publicado: (2019)

Isoprocurcumenol Supports Keratinocyte Growth and Survival through Epidermal Growth Factor Receptor Activation
por: Paul Kwangho Kwon, et al.
Publicado: (2021)

Optimization, Characterization and in vivo Evaluation of Paclitaxel-Loaded Folate-Conjugated Superparamagnetic Iron Oxide Nanoparticles
por: Gui G, et al.
Publicado: (2021)

Fibroblast growth factor receptor facilitates recurrence of minimal residual disease following trastuzumab emtansine therapy
por: Saeed S. Akhand, et al.
Publicado: (2021)

Folate-conjugated boron nitride nanospheres for targeted delivery of anticancer drug
por: Feng S, et al.
Publicado: (2016)

Targeted delivery of thymosin beta 4 to the injured myocardium using CREKA-conjugated nanoparticles
por: Huang Z, et al.
Publicado: (2017)

Efficient Anti-Glioma Therapy Through the Brain-Targeted RVG15-Modified Liposomes Loading Paclitaxel-Cholesterol Complex
por: Xin X, et al.
Publicado: (2021)

Co-Delivery of Curcumin and Paclitaxel by “Core-Shell” Targeting Amphiphilic Copolymer to Reverse Resistance in the Treatment of Ovarian Cancer
por: Zhao MD, et al.
Publicado: (2019)

The epidermal growth factor receptor is involved in angiotensin II but not aldosterone/salt-induced cardiac remodelling.
por: Smail Messaoudi, et al.
Publicado: (2012)

Exploring the role of epidermal growth factor receptor variant III in meningeal tumors.
por: Rashmi Rana, et al.
Publicado: (2021)

ANALYSIS OF IMMUNOHISTOCHEMICAL EXPRESSION OF EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) IN COLORECTAL CANCER
por: Ghazala Sadaf, et al.
Publicado: (2020)